Biocytogen HK$549 million IPO
We advised Biocytogen on its IPO and HKEX listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Assertio $70 million convertible senior notes offering
The 6.5% notes are due 2027
Oak Street Health $180.3 million secondary offering
We advised the joint book-running managers on the equity offering
Tenaya Therapeutics $75 million at-the-market offering
The common stock is listed on the Nasdaq Global Select Market
ADC Therapeutics $175 million term loan facility and other financings
We advised the company on the new facility, a $115 million exchange and a $6.25 million share sale
Terns Pharmaceuticals $65 million common stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Vaccitech $75 million at-the-market offering
The ADSs are listed on the Nasdaq Global Market
RxSight $50 million at-the-market offering
The stock is listed on the Nasdaq Global Market
TransMedics Group $150 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Allakos $75 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market